The Liraglutide Trial

The Liraglutide Trial
This GLP-1 receptor agonist study will test the efficacy and safety of liraglutide in the treatment of people with idiopathic Parkinson's (of no known cause). The trial is taking place at the Cedars-Sinai Medical Center, Los Angeles, U.S. and was selected by the Linked Clinical Trials committee and is co-funded by The Cure Parkinson's Trust and the Van Andel Institute. ... read more
Source: Published on 2019-01-16